UPDATE : Friday, July 10, 2020
HOME Policy
KHIDI, RIGHT Fund to cooperate on infectious disease research
  • By Shim Hyun-tai
  • Published 2020.05.25 17:02
  • Updated 2020.05.26 11:49
  • comments 0

The Korea Health Industry Development Institute (KHIDI) and RIGHT Fund, a three-way fund for public health promotion, agreed last Friday to step up cooperation on research and development (R&D) concerning infectious diseases.

The state-run agency and Research Investment for Global Health Technology (RIGHT) Fund – created by contributions from the government, some private companies, and the Bill & Melinda Gates Foundation -- signed a memorandum of understating on the sidelines of annual "Bio Korea 2020" event.

Kwon Deok-cheol (left), director of the Korea Health Industry Development Institute (KHIDI), and Moon Chang-jin, chairman of RIGHT Fund, signed an MOU to step up cooperation on research and development concerning infectious diseases at KHIDI last Friday.

Their goal is to support domestic R&D and promote international cooperation on new and endemic infectious diseases, the institute said in a press release.

Under the agreement, the institute and the fund will establish a channel that helps exchange R&D information of domestic health and medical technology before the RIGHT Fund's third project on medium- and large-scale research on infectious diseases begins.

The channel covers information on domestic healthcare technology on new infectious diseases, such as Covid-19, and endemic diseases in developing countries.

The two organizations agreed to cooperate on preparing measures to support research institutions and companies that struggle to respond to infectious diseases more effectively.


<© Korea Biomedical Review, All rights reserved.>

Other articles by Shim Hyun-tai
iconMost viewed
Comments 0
Please leave the first comment.
Back to Top